A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen®) 200 mg/5 ml Oral Suspension

Clinical trial NCT07036861 · COMPLETED

Trial details

NCT number: NCT07036861
Sponsor: Berlin-Chemie AG Menarini Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Male and Female Subjects

Start date: 2023-11-06
Primary completion: 2024-04-08
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.